The Research Council of Finland has granted approximately 1.7 million euros of funding to the University of Eastern Finland in the 2025 Proof of Concept call. Six projects at the University of Eastern Finland secured funding.
The Research Council of Finland granted a total of 9.7 million euros to 27 projects. The projects start on 1 January 2026 and run for two years.
The Research Council of Finland’s Proof of Concept scheme supports research projects in taking their ideas towards commercialisation and generating other societal impact. The funding encourages researchers to, for example, test their research results in practical settings or develop new approaches to address the needs of industry, public administration or the third sector. The Research Council of Finland monitors the impact of the research projects.
New Proof of Concept projects at the University of Eastern Finland:
- Developing a new generation of plant elicitors. Principal Investigator: Professor James Blande, Department of Environmental and Biological Sciences. Granted funding: 299,917 euros, total funding: 428,452 euros.
- Translating AI biomarker discovery solutions into clinical and industrial use. Principal Investigator: Associate Professor Vittorio Fortino, Institute of Biomedicine. Granted funding: 212,210 euros, total funding: 303,158 euros.
- From lab to plates - co-creating and scaling up plant cell cultures for food manufacturing. Principal Investigator: Professor Marjukka Kolehmainen, Institute of Public Health and Clinical Nutrition. Granted funding: 160,700 euros, total funding: 229,571 euros.
- Waveform-based prediction of AD-related pathology for patient diagnostics. Principal Investigator: Professor Ville Leinonen, School of Medicine. Granted funding: 225,001 euros, total funding: 321,430 euros.
- Waveform-based prediction of AD-related pathology for patient diagnostics. Principal Investigator: Professor Tarja Malm, A.I. Virtanen Institute for Molecular Sciences. Granted funding: 224,997 euros, total funding: 321,424 euros.
- A toolkit for tackling hate speech – managing the production, experiencing, and witnessing of hate speech in the digital age (TACKLEHATE). Principal Investigator: Professor Tuija Saresma, School of Humanities. Granted funding: 264,066 euros, total funding: 377,237 euros.
- Gene therapy for the treatment of severe coronary heart disease and heart failure using a minimally invasive new percutaneous retrograde catheter application. Principal Investigator: Professor Seppo Ylä-Herttuala, A.I. Virtanen Institute for Molecular Sciences. Granted funding: 290,520 euros, total funding: 416,520 euros.
Press release source: Research Council of Finland